The liver, a remarkable organ, plays a pivotal role in maintaining the body's intricate balance by executing multifaceted functions such as immune defense, detoxification, and the secretion of bile. Its contributions extend to the synthesis of essential proteins, clotting factors, and cholesterol. The liver's indispensability is underscored by the dire consequences that arise when it malfunctions, posing a substantial threat to one's life. A spectrum of acute and chronic liver diseases, including hepatitis, non-alcoholic fatty liver disease, liver cancer, tumors, and cirrhosis, underscores the organ's vulnerability.
Manifestations of initial liver damage manifest as a spectrum of symptoms, including nausea, fatigue, diarrhea, jaundice, abdominal swelling, and mental disorientation. Timely detection is imperative, as acute liver damage can be effectively addressed through appropriate medications. However, delayed diagnosis necessitates more drastic measures such as liver transplantation, emphasizing the critical nature of intervention timing.
The burgeoning global patient population grappling with liver diseases serves as a driving force behind the expansion of the liver disease treatment market. The incidence and prevalence of liver diseases are witnessing a disturbing ascent, attributable to factors such as viral infections, alcohol abuse, escalating obesity rates, and shifts in lifestyle choices. Alarming statistics from the World Health Organization (WHO) reveal that liver diseases claim the lives of an estimated 2 million people annually, ranking as the 11th leading cause of death worldwide.
The prevalence of hepatitis B and C further compounds the global health challenge, with approximately 257 million individuals affected by the former and 71 million by the latter in 2019. WHO highlights that 20% to 50% of liver cirrhosis cases are attributed to alcohol consumption, emphasizing the need for comprehensive preventive strategies. Adopting a healthy lifestyle and practicing proper hygiene emerge as pivotal measures in averting liver damage, offering a glimmer of hope in the face of a mounting public health crisis. The imperative lies in fostering awareness, early detection, and prioritizing interventions to curtail the escalating burden of liver diseases on a global scale.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Anti-Rejection Drugs/Immunosupressants
Chemotherapy Drugs
Targeted therapy
Vaccines
Others
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Adult
Children
Company Coverage (Sales data, Main Products & Services etc.):
Gilead Science
Bayer AG
AstraZeneca
GlaxoSmithKline
Merck & Co
Sanofi
Pfizer
F. Hoffmann-La Roche
Novartis AG
Johnson &Johnson
Major Region Market
North America
Europe
Asia-Pacific
South America
Middle East & Africa"
Table of Content
1 Industry Overview
1.1 Liver Disease Treatment Industry
1.1.1 Overview
1.1.2 Products of Major Companies
1.2 Market Segment
1.2.1 Industry Chain
1.2.2 Consumer Distribution
1.3 Price & Cost Overview
2 Liver Disease Treatment Market by Type
2.1 By Type
2.1.1 Anti-Rejection Drugs/Immunosupressants
2.1.2 Chemotherapy Drugs
2.1.3 Targeted therapy
2.1.4 Vaccines
2.1.5 Others
2.2 Market Size by Type
2.3 Market Forecast by Type
3 Global Market Demand
3.1 Segment Overview
3.1.1 Adult
3.1.2 Children
3.2 Market Size by Demand
3.3 Market Forecast by Demand
4 Major Region Market
4.1 Global Market Overview
4.1.1 Market Size & Growth
4.1.2 Market Forecast
4.2 Major Region
4.2.1 Market Size & Growth
4.2.2 Market Forecast
5 Major Companies List
5.1 Gilead Science (Company Profile, Sales Data etc.)
5.2 Bayer AG (Company Profile, Sales Data etc.)
5.3 AstraZeneca (Company Profile, Sales Data etc.)
5.4 GlaxoSmithKline (Company Profile, Sales Data etc.)
5.5 Merck & Co (Company Profile, Sales Data etc.)
5.6 Sanofi (Company Profile, Sales Data etc.)
5.7 Pfizer (Company Profile, Sales Data etc.)
5.8 F. Hoffmann-La Roche (Company Profile, Sales Data etc.)
5.9 Novartis AG (Company Profile, Sales Data etc.)
5.10 Johnson &Johnson (Company Profile, Sales Data etc.)
6 Conclusion
List of Table
Table Global Liver Disease Treatment Market 2016-2019, by Type, in USD Million
Table Global Liver Disease Treatment Market 2016-2019, by Type, in Volume
Table Global Liver Disease Treatment Market Forecast 2020-2026, by Type, in USD Million
Table Global Liver Disease Treatment Market Forecast 2020-2026, by Type, in Volume
Table Global Liver Disease Treatment Demand 2016-2019, in USD Million
Table Global Liver Disease Treatment Demand 2016-2019, in Volume
Table Global Liver Disease Treatment Demand Forecast 2020-2026, in USD Million
Table Global Liver Disease Treatment Demand Forecast 2020-2026, in Volume
Table Global Liver Disease Treatment Market Size & Growth 2016-2019, in USD Million
Table Global Liver Disease Treatment Market Size & Growth 2016-2019, in Volume
Table Global Liver Disease Treatment Market Forecast 2020-2026, in USD Million
Table Global Liver Disease Treatment Market Forecast 2020-2026, in Volume
Table Global Liver Disease Treatment Market 2016-2019, by Region, in USD Million
Table Global Liver Disease Treatment Market 2016-2019, by Region, in Volume
Table Global Liver Disease Treatment Market Forecast 2020-2026, by Region, in USD Million
Table Global Liver Disease Treatment Market Forecast 2020-2026, by Region, in Volume
Table Gilead Science Overview List
Table Liver Disease Treatment Business Operation of Gilead Science (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gilead Science Overview List
Table Liver Disease Treatment Business Operation of Gilead Science (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer AG Overview List
Table Liver Disease Treatment Business Operation of Bayer AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca Overview List
Table Liver Disease Treatment Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline Overview List
Table Liver Disease Treatment Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck & Co Overview List
Table Liver Disease Treatment Business Operation of Merck & Co (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Liver Disease Treatment Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Liver Disease Treatment Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table F. Hoffmann-La Roche Overview List
Table Liver Disease Treatment Business Operation of F. Hoffmann-La Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis AG Overview List
Table Liver Disease Treatment Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson &Johnson Overview List
Table Liver Disease Treatment Business Operation of Johnson &Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
List of Figure
Figure Global Liver Disease Treatment Market Growth 2016-2019, by Type, in USD Million
Figure Global Liver Disease Treatment Market Growth 2016-2019, by Type, in Volume
Get Discount